Free Corporate Rating
Discover how companies are aligning with the Paris Agreementâs goal of limiting global warming to 2°C. This tool provides you with up-to-date climate ratings, reflecting a companyâs progress and commitment to sustainable practices. Whether you're an investor, policymaker, or eco-conscious consumer, our platform simplifies your search for transparent, data-driven insights on corporate climate performance.
Start exploring now and make informed decisions for a sustainable future !
NOVO NORDISK A/S
Health Care
ISIN
DK0062498333
LEI
549300DAQ1CVT6CXN342
Description
Novo Nordisk A/S is a global healthcare company that specializes in diabetes care, biopharmaceuticals, and obesity treatments. They develop and market products and services to help people with diabetes and other chronic diseases lead healthier lives.
Transitioning
⢠Condition: 2°C ⤠SB2A < 3°C and decreasing GHG intensity without any target
⢠Description: Transitioning companies, despite the absence of a reduction target, are engaged in reducing their carbon footprint. The decrease in the GHG intensity at issuer level is the sign that these companies are making strides toward sustainability, even if a specific reduction target is yet to be formalized.
Rating peers in sector of Health Care (based on 275 companies)
19%
Leader
7%
Aligned
4%
Actively
transitioning
NOVO NORDISK A/S
29%
Transitioning
35%
Not
aligned
7%
Laggard
Discover other companies in Health Care with Transitioning score
Get in touch!
Want to know more? Fill out the form or reach us directly via email at contact@icebergdatalab.com.
France
ICEBERG DATA LAB
87 Rue Saint-Lazare
75009 Paris
75009 Paris
đ +33 1 89 71 64 00
United Kingdom
ICEBERG DATA LAB
1 Fore Street Avenue
EC2Y 9DT London
EC2Y 9DT London
đ +44 20 4634 7956
Germany
ICEBERG DATA LAB
Platz der Einheit 2
60327 Frankfurt am Main, Frankfurt
60327 Frankfurt am Main, Frankfurt
United States
ICEBERG DATA LAB
100 Cummings Center
Beverly, MA 01915
Beverly, MA 01915
đ +1 (351) 235-2879
